Ria Lassaunière (Ria Lassauniere)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Inflammatory Response

Respiratory Syndrome Coronavirus

Circulating Tumor

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Rana Abdelnabi, Ria Lassaunière, Piet Maes, Birgit Weynand, Johan Neyts
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses 16 (1) (2024)
Rana Abdelnabi, Ria Lassaunière, Piet Maes, Birgit Weynand, Johan Neyts
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses 16 (1) (2024)
Rana Abdelnabi, Ria Lassaunière, Piet Maes, Birgit Weynand, Johan Neyts
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses 16 (1) (2024)
Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12 (3) (2024)
Rana Abdelnabi, Ria Lassaunière, Piet Maes, Birgit Weynand, Johan Neyts
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses 16 (1) (2024)
Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12 (3) (2024)
Rana Abdelnabi, Ria Lassaunière, Piet Maes, Birgit Weynand, Johan Neyts
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses 16 (1) (2024)
Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12 (3) (2024)
Anders Frische, Vithiagaran Gunalan, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies. Vaccines 11 (9) (2023)
Frederik Plesner Lyngse, Laust Hvas Mortensen, Matthew J Denwood, Lasse Engbo Christensen, Camilla Holten Møller, Robert Leo Skov, Katja Spiess, Anders Fomsgaard, Ria Lassaunière, Morten Rasmussen, Marc Stegger, Claus Nielsen, Raphael Niklaus Sieber, Arieh Sierra Cohen, Frederik Trier Møller, Maria Overvad, Kåre Mølbak, Tyra Grove Krause, Carsten Thure Kirkeby
Household transmission of the SARS-CoV-2 Omicron variant in Denmark. Nature communications 13 (1) (2022)
Anders Frische, Patrick Terrence Brooks, Mikkel Gybel-Brask, Susanne Gjørup Sækmose, Bitten Aagaard Jensen, Susan Mikkelsen, Mie Topholm Bruun, Lasse Boding, Charlotta Polacek Strandh, Charlotte Sværke Jørgensen, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay. PloS one 17 (7) (2022)
Thomas Bruun Rasmussen, Jannik Fonager, Charlotte Sværke Jørgensen, Ria Lassaunière, Anne Sofie Hammer, Michelle Lauge Quaade, Anette Boklund, Louise Lohse, Bertel Strandbygaard, Morten Rasmussen, Thomas Yssing Michaelsen, Sten Mortensen, Anders Fomsgaard, Graham J Belsham, Anette Bøtner
Infection, recovery and re-infection of farmed mink with SARS-CoV-2. PLoS pathogens 17 (11) (2021)
Ria Lassaunière, Charlotta Polacek, Gregers J Gram, Anders Frische, Jeanette Linnea Tingstedt, Maren Krüger, Brigitte Gertrud Dorner, Anthony Cook, Renita Brown, Tatyana Orekov, Tammy Putmon-Taylor, Tracey-Ann Campbell, Jack Greenhouse, Laurent Pessaint, Hanne A Elyard, Mark G Lewis, Anders Fomsgaard
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2. NPJ vaccines 6 (1) (2021)